关注
Smruthy Sivakumar
Smruthy Sivakumar
Foundation Medicine, Inc.
在 foundationmedicine.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genomic landscape of atypical adenomatous hyperplasia reveals divergent modes to lung adenocarcinoma
S Sivakumar, FAS Lucas, TL McDowell, W Lang, L Xu, J Fujimoto, ...
Cancer research 77 (22), 6119-6130, 2017
1012017
Concordance of DNA repair gene mutations in paired primary prostate cancer samples and metastatic tissue or cell-free DNA
MT Schweizer, S Sivakumar, H Tukachinsky, I Coleman, N De Sarkar, ...
JAMA oncology 7 (9), 1378-1382, 2021
612021
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
JK Lee, S Sivakumar, AB Schrock, R Madison, D Fabrizio, O Gjoerup, ...
NPJ Precision Oncology 6 (1), 91, 2022
592022
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation
S Sivakumar, JA Moore, M Montesion, R Sharaf, DI Lin, CI Colón, ...
Cancer discovery 13 (7), 1572-1591, 2023
462023
Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer
YA Jakubek, K Chang, S Sivakumar, Y Yu, MR Giordano, J Fowler, ...
Nature biotechnology 38 (1), 90-96, 2020
392020
Histiocytic and dendritic cell sarcomas of hematopoietic origin share targetable genomic alterations distinct from follicular dendritic cell sarcoma
LR Massoth, YP Hung, JA Ferry, RP Hasserjian, V Nardi, GP Nielsen, ...
The oncologist 26 (7), e1263-e1272, 2021
382021
Driver mutations in normal airway epithelium elucidate spatiotemporal resolution of lung cancer
H Kadara, S Sivakumar, Y Jakubek, FA San Lucas, W Lang, T McDowell, ...
American journal of respiratory and critical care medicine 200 (6), 742-750, 2019
272019
Augmented lipocalin-2 is associated with chronic obstructive pulmonary disease and counteracts lung adenocarcinoma development
W Treekitkarnmongkol, M Hassane, A Sinjab, K Chang, K Hara, Z Rahal, ...
American Journal of Respiratory and Critical Care Medicine 203 (1), 90-101, 2021
262021
Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform
A Deshpande, W Lang, T McDowell, S Sivakumar, J Zhang, J Wang, ...
BMC bioinformatics 19, 1-10, 2018
242018
Rapid and powerful detection of subtle allelic imbalance from exome sequencing data with hapLOHseq
FA San Lucas, S Sivakumar, S Vattathil, J Fowler, E Vilar, P Scheet
Bioinformatics 32 (19), 3015-3017, 2016
222016
TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection
AA Khalil, S Sivakumar, FA San Lucas, T McDowell, W Lang, K Tabata, ...
Oncotarget 8 (40), 68230, 2017
212017
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer
S Sivakumar, DX Jin, H Tukachinsky, K Murugesan, K McGregor, ...
Nature Communications 13 (1), 7495, 2022
202022
Genome-wide gene expression changes in the normal-appearing airway during the evolution of smoking-associated lung adenocarcinoma
J Kantrowitz, A Sinjab, L Xu, TL McDowell, S Sivakumar, W Lang, ...
Cancer Prevention Research 11 (4), 237-248, 2018
192018
Genomic characterization of thymic epithelial tumors in a real-world dataset
K Kurokawa, T Shukuya, RA Greenstein, BG Kaplan, H Wakelee, JS Ross, ...
ESMO open 8 (5), 101627, 2023
132023
Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung
S Sivakumar, FA San Lucas, YA Jakubek, TL McDowell, W Lang, ...
EBioMedicine 42, 296-303, 2019
132019
Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma
HS Rugo, K Raskina, AB Schrock, RW Madison, RP Graf, ES Sokol, ...
Clinical Cancer Research 29 (6), 1056-1067, 2023
122023
Ancestral characterization of the genomic landscape, comprehensive genomic profiling utilization, and treatment patterns may inform disparities in advanced prostate cancer: A …
S Sivakumar, JK Lee, JA Moore, J Hopkins, J Newberg, AB Schrock, ...
Journal of Clinical Oncology 39 (15_suppl), 5003-5003, 2021
122021
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
KE Hutchinson, JW Chen, HM Savage, TJ Stout, F Schimmoller, J Cortés, ...
Genome Medicine 15 (1), 28, 2023
112023
Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple PIK3CA Mutations
S Sivakumar, DX Jin, R Rathod, J Ross, LC Cantley, M Scaltriti, JW Chen, ...
Clinical Cancer Research 29 (6), 1125-1136, 2023
112023
Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
TV Pham, AM Goodman, S Sivakumar, G Frampton, R Kurzrock
Genome Medicine 13, 1-9, 2021
112021
系统目前无法执行此操作,请稍后再试。
文章 1–20